Gad Thomas — SEC Form 4 filings
SEC reporting owner CIK 1753224. 10 Form 4 filings on record with FilingPulse; latest filed 2025-09-18.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-01-22 to 2025-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 212,061 shares, $2,621,915 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 26.
- Largest priced transaction: sale of 65,000 shares @ $13.47 ($875,550) in Y-mAbs Therapeutics, Inc., filed 2024-09-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. (YMAB) | CHIEF BUSINESS OFFICER, Director | 10 | — | 8 legs · 212,061 sh · $2,621,915 | 26 |
Form 4 filings — Gad Thomas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-09-18 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Code (U): 245,486 @ $8.60 · Disposition to issuer (D): 60,235 · Code (U): 67,681 @ $8.60 · Code (U): 60,000 @ $8.60 · Disposition to issuer (D): 143,169 (derivative) · Disposition to issuer (D): 16,000 (derivative) · +12 more | EDGAR |
| 2025-06-05 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Option exercise (M): 103,000 @ $2 · Option exercise (M): 103,000 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale (S): 10,810 @ $5.23 | EDGAR |
| 2025-01-22 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 32,000 @ $0 · Grant/award (A): 64,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Option exercise (M): 22,831 @ $4.38 · Option exercise (M): 22,831 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale (S): 65,000 @ $13.47 · Sale (S): 30,000 @ $12.97 | EDGAR |
| 2024-06-11 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale (S): 35,000 @ $12.03 · Sale (S): 35,000 @ $12 | EDGAR |
| 2024-05-23 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale (S): 25,000 @ $12 · Sale (S): 7,351 @ $13 | EDGAR |
| 2024-03-07 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Sale (S): 3,900 @ $16.44 | EDGAR |
| 2024-01-22 | 4 | Y-mAbs Therapeutics, Inc. (YMAB) | Grant/award (A): 22,100 @ $0 · Grant/award (A): 132,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1753224 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →